Tryptophan-Derived 3-Hydroxyanthranilic Acid Contributes to Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice in Vivo

Circulation

Volumn 136, Issue 23, 2017, Pages 2271-2283

  Wang, Qiongxin ^a   Ding, Ye ^b   Song, Ping ^b   Zhu, Huaiping ^c   Okon, Imoh ^b   Ding, Yang Nan ^c   Chen, Hou Zao ^c   Liu, De Pei ^c   Zou, Ming Hui ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

3 hydroxyanthranilic acid; angiotensin II; aortic aneurysm, abdominal; indoleamine pyrrole 2,3 dioxygenase; matrix metallopeptidases; tryptophan

Indexed keywords

3 HYDROXYANTHRANILIC ACID; ANGIOTENSIN II; ANTIBODY; APOLIPOPROTEIN E; GAMMA INTERFERON; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINASE; KYNURENINE; TRANSCRIPTION FACTOR; TRYPTOPHAN; HYDROLASE; IFNG PROTEIN, MOUSE; MMP2 PROTEIN, MOUSE;

ABDOMINAL AORTIC ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTIC SMOOTH MUSCLE CELL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS BREEDING; ENZYME ACTIVITY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRYPTOPHAN METABOLISM; UPREGULATION; ABDOMINAL AORTA; ANIMAL; APOLIPOPROTEIN E KNOCKOUT MOUSE; BONE MARROW TRANSPLANTATION; CELL CULTURE; CHEMICALLY INDUCED; DISEASE MODEL; ELASTIC TISSUE; GENETICS; GENOTYPE; LESIONS AND DEFECTS; METABOLISM; PATHOLOGY; PHENOTYPE; SMOOTH MUSCLE CELL; TIME FACTOR; VASCULAR SMOOTH MUSCLE;

3-HYDROXYANTHRANILIC ACID; ANGIOTENSIN II; ANIMALS; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; DILATATION, PATHOLOGIC; DISEASE MODELS, ANIMAL; ELASTIC TISSUE; GENOTYPE; HUMANS; HYDROLASES; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; MATRIX METALLOPROTEINASE 2; MICE, KNOCKOUT, APOE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PHENOTYPE; TIME FACTORS; TRYPTOPHAN;

EID: 85037085504     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.117.030972     Document Type: Article

References (59)

1. Weintraub NL. Understanding abdominal aortic aneurysm. N Engl J Med. 2009;361:1114-1116. doi: 10.1056/NEJMcibr0905244.
2. Nordon IM, Hinchliffe RJ, Loftus IM, Thompson MM. Pathophysiology, epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol. 2011;8:92-102. doi: 10.1038/nrcardio.2010.180.
3. Wang S, Zhang C, Zhang M, Liang B, Zhu H, Lee J, Viollet B, Xia L, Zhang Y, Zou MH. Activation of AMP-activated protein kinase 2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo. Nat Med. 2012;18:902-910. doi: 10.1038/nm.2711.
4. Satoh K, Nigro P, Matoba T, O'Dell MR, Cui Z, Shi X, Mohan A, Yan C, Abe J, Illig KA, Berk BC. Cyclophilin A enhances vascular oxidative stress, the development of angiotensin II-induced aortic aneurysms. Nat Med. 2009;15:649-656. doi: 10.1038/nm.1958.
5. Raaz U, Zollner AM, Schellinger IN, Toh R, Nakagami F, Brandt M, Emrich FC, Kayama Y, Eken S, Adam M, Maegdefessel L, Hertel T, Deng A, Jagger A, Buerke M, Dalman RL, Spin JM, Kuhl E, Tsao PS. Segmental aortic stiffening contributes to experimental abdominal aortic aneurysm development. Circulation. 2015;131:1783-1795. doi: 10.1161/CIRCULATIONAHA. 114.012377.
6. Wang Q, Liu D, Song P, Zou MH. Tryptophan-kynurenine pathway is dysregulated in inflammation, immune activation. Front Biosci (Landmark Ed). 2015;20:1116-1143.
7. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB. Tryptophan-derived catabolites are responsible for inhibition of T, natural killer cell proliferation induced by indoleamine 2, 3-dioxygenase. J Exp Med. 2002;196:459-468.
8. Matino D, Gargaro M, Santagostino E, Di Minno MN, Castaman G, Morfini M, Rocino A, Mancuso ME, Di Minno G, Coppola A, Talesa VN, Volpi C, Vacca C, Orabona C, Iannitti R, Mazzucconi MG, Santoro C, Tosti A, Chiappalupi S, Sorci G, Tagariello G, Belvini D, Radossi P, Landolfi R, Fuchs D, Boon L, Pirro M, Marchesini E, Grohmann U, Puccetti P, Iorio A, Fallarino F. IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII. J Clin Invest. 2015;125:3766-3781. doi: 10.1172/JCI81859.
9. Wang Y, Liu H, McKenzie G, Witting PK, Stasch JP, Hahn M, Changsirivathanathamrong D, Wu BJ, Ball HJ, Thomas SR, Kapoor V, Celermajer DS, Mellor AL, Keaney JF Jr, Hunt NH, Stocker R. Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med. 2010;16:279-285. doi: 10.1038/nm.2092.
10. Wang Q, Zhang M, Ding Y, Wang Q, Zhang W, Song P, Zou MH. Activation of NAD(P)H oxidase by tryptophan-derived 3-hydroxykynurenine accelerates endothelial apoptosis, dysfunction in vivo. Circ Res. 2014;114:480-492. doi: 10.1161/CIRCRESAHA.114.302113.
11. Jones SP, Franco NF, Varney B, Sundaram G, Brown DA, de Bie J, Lim CK, Guillemin GJ, Brew BJ. Expression of the kynurenine pathway in human peripheral blood mononuclear cells: Implications for inflammatory, neurodegenerative disease. PLoS One. 2015;10:e0131389. doi: 10.1371/journal.pone.0131389.
12. Platten M, von Knebel Doeberitz N, Oezen I, Wick W, Ochs K. Cancer Immunotherapy by targeting IDO1/TDO, their downstream effectors. Front Immunol. 2014;5:673. doi: 10.3389/fimmu.2014.00673.
13. Campbell BM, Charych E, Lee AW, Moller T. Kynurenines in CNS disease: Regulation by inflammatory cytokines. Front Neurosci. 2014;8:12. doi: 10.3389/fnins.2014.00012.
14. Hofmann F. Ido brings down the pressure in systemic inflammation. Nat Med. 2010;16:265-267. doi: 10.1038/nm0310-265.
15. Changsirivathanathamrong D, Wang Y, Rajbhandari D, Maghzal GJ, Mak WM, Woolfe C, Duflou J, Gebski V, dos Remedios CG, Celermajer DS, Stocker R. Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis. Crit Care Med. 2011;39:2678-2683. doi: 10.1097/CCM.0b013e31822827f2.
16. Ristagno G, Fries M, Brunelli L, Fumagalli F, Bagnati R, Russo I, Staszewsky L, Masson S, Li Volti G, Zappala A, Derwall M, Brucken A, Pastorelli R, Latini R. Early kynurenine pathway activation following cardiac arrest in rats, pigs, humans. Resuscitation. 2013;84:1604-1610. doi: 10.1016/j. resuscitation.2013.06.002.
17. Cole JE, Astola N, Cribbs AP, Goddard ME, Park I, Green P, Davies AH, Williams RO, Feldmann M, Monaco C. Indoleamine 2, 3-dioxygenase-1 is protective in atherosclerosis, its metabolites provide new opportunities for drug development. Proc Natl Acad Sci USA. 2015;112:13033-13038. doi: 10.1073/pnas.1517820112.
18. Metghalchi S, Ponnuswamy P, Simon T, Haddad Y, Laurans L, Clement M, Dalloz M, Romain M, Esposito B, Koropoulis V, Lamas B, Paul JL, Cottin Y, Kotti S, Bruneval P, Callebert J, den Ruijter H, Launay JM, Danchin N, Sokol H, Tedgui A, Taleb S, Mallat Z. Indoleamine 2, 3-dioxygenase fine-tunes immune homeostasis in atherosclerosis, colitis through repression of interleukin-10 production. Cell Metab. 2015;22:460-471. doi: 10.1016/j. cmet.2015.07.004.
19. Song P, Ramprasath T, Wang H, Zou M-H. Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases. Cell Mol Life Sci. 2017;74:2899-2916.
20. Krettek A, Sukhova GK, Libby P. Elastogenesis in human arterial disease: A role for macrophages in disordered elastin synthesis. Arterioscler Thromb Vasc Biol. 2003;23:582-587. doi: 10.1161/01.ATV.0000064372.78561. A5.
21. Daugherty A, Cassis LA, Lu H. Complex pathologies of angiotensin II-induced abdominal aortic aneurysms. J Zhejiang Univ Sci B. 2011;12:624-628. doi: 10.1631/jzus.B1101002.
22. Rateri DL, Howatt DA, Moorleghen JJ, Charnigo R, Cassis LA, Daugherty A. Prolonged infusion of angiotensin II in apoE(-/-) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm. Am J Pathol. 2011;179:1542-1548. doi: 10.1016/j.ajpath. 2011.05.049.
23. Cassis LA, Gupte M, Thayer S, Zhang X, Charnigo R, Howatt DA, Rateri DL, Daugherty A. ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice. Am J Physiol Heart Circ Physiol. 2009;296:H1660-H1665. doi: 10.1152/ajpheart.00028.2009.
24. Daugherty A, Cassis LA. Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2004;24:429-434. doi: 10.1161/01. ATV.0000118013.72016.ea.
25. Owens AP III, Rateri DL, Howatt DA, Moore KJ, Tobias PS, Curtiss LK, Lu H, Cassis LA, Daugherty A. MyD88 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation independent of signaling through Toll-like receptors 2, 4. Arterioscler Thromb Vasc Biol. 2011;31:2813-2819. doi: 10.1161/ATVBAHA.111.238642.
26. Qin Z, Bagley J, Sukhova G, Baur WE, Park HJ, Beasley D, Libby P, Zhang Y, Galper JB. Angiotensin II-induced TLR4 mediated abdominal aortic aneurysm in apolipoprotein E knockout mice is dependent on STAT3. J Mol Cell Cardiol. 2015;87:160-170. doi: 10.1016/j.yjmcc.2015.08.014.
27. Hellenthal FA, Buurman WA, Wodzig WK, Schurink GW. Biomarkers of AAA progression. Part 1: Extracellular matrix degeneration. Nat Rev Cardiol. 2009;6:464-474. doi: 10.1038/nrcardio.2009.80.
28. Airhart N, Brownstein BH, Cobb JP, Schierding W, Arif B, Ennis TL, Thompson RW, Curci JA. Smooth muscle cells from abdominal aortic aneurysms are unique, can independently, synergistically degrade insoluble elastin. J Vasc Surg. 2014;60:1033-1041; discussion 1041. doi: 10.1016/j. jvs.2013.07.097.
29. Dilme JF, Bellmunt S, Camacho M, Sola-Villa D, Romero JM, Escudero JR, Vila L. Influence of cardiovascular risk factors on levels of matrix metalloproteinases 2, 9 in human abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2014;48:374-381. doi: 10.1016/j.ejvs.2014.05.023.
30. Gong Y, Hart E, Shchurin A, Hoover-Plow J. Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J Clin Invest. 2008;118:3012-3024. doi: 10.1172/JCI32750.
31. Varga J, Yufit T, Hitraya E, Brown RR. Control of extracellular matrix degradation by interferon-gamma. The tryptophan connection. Adv Exp Med Biol. 1996;398:143-148.
32. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med. 1999;189:1363-1372.
33. Snedden W, Mellor CS, Martin JR. Familial hypertryptophanemia, tryptophanuria, indoleketonuria. Clin Chim Acta. 1983;131:247-256.
34. Martin JR, Mellor CS, Fraser FC. Familial hypertryptophanemia in two siblings. Clin Genet. 1995;47:180-183.
35. Andrade VS, Rojas DB, Oliveira L, Nunes ML, de Castro FL, Garcia C, Gemelli T, de Andrade RB, Wannmacher CM. Creatine, pyruvate prevent behavioral, oxidative stress alterations caused by hypertryptophanemia in rats. Mol Cell Biochem. 2012;362:225-232. doi: 10.1007/s11010-011-1147-0.
36. Becerra A, Warke RV, Xhaja K, Evans B, Evans J, Martin K, de Bosch N, Rothman AL, Bosch I. Increased activity of indoleamine 2, 3-dioxygenase in serum from acutely infected dengue patients linked to gamma interferon antiviral function. J Gen Virol. 2009;90(pt 4):810-817. doi: 10.1099/vir.0.004416-0.
37. Kiank C, Zeden JP, Drude S, Domanska G, Fusch G, Otten W, Schuett C. Psychological stress-induced, IDO1-dependent tryptophan catabolism: Implications on immunosuppression in mice, humans. PLoS One. 2010;5:e11825. doi: 10.1371/journal.pone.0011825.
38. Polyzos KA, Ovchinnikova O, Berg M, Baumgartner R, Agardh H, Pirault J, Gistera A, Assinger A, Laguna-Fernandez A, Back M, Hansson GK, Ketelhuth DF. Inhibition of indoleamine 2, 3-dioxygenase promotes vascular inflammation, increases atherosclerosis in Apoe-/-mice. Cardiovasc Res. 2015;106:295-302. doi: 10.1093/cvr/cvv100.
39. Zhang L, Ovchinnikova O, Jonsson A, Lundberg AM, Berg M, Hansson GK, Ketelhuth DF. The tryptophan metabolite 3-hydroxyanthranilic acid lowers plasma lipids, decreases atherosclerosis in hypercholesterolaemic mice. Eur Heart J. 2012;33:2025-2034. doi: 10.1093/eurheartj/ehs175.
40. Yan Y, Zhang GX, Gran B, Fallarino F, Yu S, Li H, Cullimore ML, Rostami A, Xu H. IDO upregulates regulatory T cells via tryptophan catabolite, suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis. J Immunol. 2010;185:5953-5961. doi: 10.4049/jimmunol.1001628.
41. Krause D, Suh HS, Tarassishin L, Cui QL, Durafourt BA, Choi N, Bauman A, Cosenza-Nashat M, Antel JP, Zhao ML, Lee SC. The tryptophan metabolite 3-hydroxyanthranilic acid plays anti-inflammatory, neuroprotective roles during inflammation: Role of hemeoxygenase-1. Am J Pathol. 2011;179:1360-1372. doi: 10.1016/j.ajpath.2011.05.048.
42. Klein C, Patte-Mensah C, Taleb O, Bourguignon JJ, Schmitt M, Bihel F, Maitre M, Mensah-Nyagan AG. The neuroprotector kynurenic acid increases neuronal cell survival through neprilysin induction. Neuropharmacology. 2013;70:254-260. doi: 10.1016/j.neuropharm.2013.02.006.
43. Terness P, Bauer TM, Rose L, Dufter C, Watzlik A, Simon H, Opelz G. Inhibition of allogeneic T cell proliferation by indoleamine 2, 3-dioxygenaseexpressing dendritic cells: Mediation of suppression by tryptophan metabolites. J Exp Med. 2002;196:447-457.
44. Malina HZ, Richter C, Mehl M, Hess OM. Pathological apoptosis by xanthurenic acid, a tryptophan metabolite: Activation of cell caspases but not cytoskeleton breakdown. BMC Physiol. 2001;1:7.
45. Hayashi T, Mo JH, Gong X, Rossetto C, Jang A, Beck L, Elliott GI, Kufareva I, Abagyan R, Broide DH, Lee J, Raz E. 3-Hydroxyanthranilic acid inhibits PDK1 activation, suppresses experimental asthma by inducing T cell apoptosis. Proc Natl Acad Sci USA. 2007;104:18619-18624. doi: 10.1073/pnas.0709261104.
46. Nischan J, Gatalica Z, Curtis M, Lenk GM, Tromp G, Kuivaniemi H. Binding sites for ETS family of transcription factors dominate the promoter regions of differentially expressed genes in abdominal aortic aneurysms. Circ Cardiovasc Genet. 2009;2:565-572. doi: 10.1161/CIRCGENETICS.108.843854.
47. Cummins PM, von Offenberg Sweeney N, Killeen MT, Birney YA, Redmond EM, Cahill PA. Cyclic strain-mediated matrix metalloproteinase regulation within the vascular endothelium: A force to be reckoned with. Am J Physiol Heart Circ Physiol. 2007;292:H28-H42. doi: 10.1152/ajpheart. 00304.2006.
48. Pawlak K, Myliwiec M, Pawlak D. Kynurenine pathway-A new link between endothelial dysfunction, carotid atherosclerosis in chronic kidney disease patients. Adv Med Sci. 2010;55:196-203. doi: 10.2478/v10039-010-0015-6.
49. Sulo G, Vollset SE, Nygard O, Midttun O, Ueland PM, Eussen SJ, Pedersen ER, Tell GS. Neopterin, kynurenine-tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study. Int J Cardiol. 2013;168:1435-1440. doi: 10.1016/j.ijcard.2012.12.090.
50. Niinisalo P, Oksala N, Levula M, Pelto-Huikko M, Jarvinen O, Salenius JP, Kytomaki L, Soini JT, Kahonen M, Laaksonen R, Hurme M, Lehtimaki T. Activation of indoleamine 2, 3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere vascular study. Ann Med. 2010;42:55-63. doi: 10.3109/07853890903321559.
51. Pedersen ER, Svingen GF, Schartum-Hansen H, Ueland PM, Ebbing M, Nordrehaug JE, Igland J, Seifert R, Nilsen RM, Nygard O. Urinary excretion of kynurenine, tryptophan, cardiovascular events, mortality after elective coronary angiography. Eur Heart J. 2013;34:2689-2696. doi: 10.1093/eurheartj/eht264.
52. Pawlak K, Tankiewicz J, Mysliwiec M, Pawlak D. Systemic levels of MMP2/TIMP2, cardiovascular risk in CAPD patients. Nephron Clin Pract. 2010;115:c251-c258. doi: 10.1159/000313483.
53. Pertovaara M, Raitala A, Juonala M, Lehtimaki T, Huhtala H, Oja SS, Jokinen E, Viikari JS, Raitakari OT, Hurme M. Indoleamine 2, 3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: The Cardiovascular Risk in Young Finns Study. Clin Exp Immunol. 2007;148:106-111. doi: 10.1111/j.1365-2249.2007.03325.x.
54. Li Y, Kilani RT, Rahmani-Neishaboor E, Jalili RB, Ghahary A. Kynurenine increases matrix metalloproteinase-1,-3 expression in cultured dermal fibroblasts, improves scarring in vivo. J Invest Dermatol. 2014;134:643-650. doi: 10.1038/jid.2013.303.
55. Rauch BH, Bretschneider E, Braun M, Schror K. Factor Xa releases matrix metalloproteinase-2 (MMP-2) from human vascular smooth muscle cells, stimulates the conversion of pro-MMP-2 to MMP-2: Role of MMP-2 in factor Xa-induced DNA synthesis, matrix invasion. Circ Res. 2002;90:1122-1127.
56. Breton J, Avanzi N, Magagnin S, Covini N, Magistrelli G, Cozzi L, Isacchi A. Functional characterization, mechanism of action of recombinant human kynurenine 3-hydroxylase. Eur J Biochem. 2000;267:1092-1099.
57. Quagliariello E, Papa S, Saccone C, Alifano A. Effect of 3-hydroxyanthranilic acid on the mitochondrial respiratory system. Biochem J. 1964;91:137-146.
58. Pawlak K, Kowalewska A, Mysliwiec M, Pawlak D. 3-Hydroxyanthranilic acid is independently associated with monocyte chemoattractant protein-1 (CCL2), macrophage inflammatory protein-1beta (CCL4) in patients with chronic kidney disease. Clin Biochem. 2010;43:1101-1106. doi: 10.1016/j.clinbiochem.2010.06.008.
59. Lee SM, Lee YS, Choi JH, Park SG, Choi IW, Joo YD, Lee WS, Lee JN, Choi I, Seo SK. Tryptophan metabolite 3-hydroxyanthranilic acid selectively induces activated T cell death via intracellular GSH depletion. Immunol Lett. 2010;132:53-60. doi: 10.1016/j.imlet.2010.05.008.